Oncology Med Upgrades Its OTC Market Tier Status to the "Current Information" Category

PITTSBURGH, PA , a Pittsburgh-based cancer treatment solutions group, announced today that it has upgraded its OTC market tier status to the "Current Information" category by making current information publicly available on the Pink Sheets News Service, in accordance with the Pink Sheets Guidelines for Providing Adequate Current Information.

"We have always desired full disclosure so investors can fully understand our Company and its operations," commented Dr. William Walker, CEO of Oncology Med. "We have made tremendous progress in our operations during fiscal year 2007 and we want to continue to inform the investor community of our future results. This puts our Company in one of the top OTC market tiers and will help our Company achieve broader investor interest, increase our respect in the health care community, increase our ability to raise capital on better terms in the capital markets and increase our ability to use our securities as currency for potential accretive acquisitions. We believe that this is a very important step in the evolution of our Company as we continue to strive for growth and shareholder value."

About Oncology Med, Inc.

Oncology Med is a public company engaged in the fulfillment of services related to the treatment of various cancers. It currently provides analysis and design of radiation treatment plans in order for radiation oncologists to administer radiation treatments to cancer patients. Current services facilitate radiation treatment programs ranging from external beam radiation to more advanced radiation treatment technologies.

More information about Oncology Med, Inc. can be found at www.oncologymed.com.

NOTE: This press release may contain "forward-looking statements." In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "potential," "continue" or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, competition, expected activities and expenditures as we pursue our business plan, and the adequacy of our available cash resources. Although we believe that the expectations reflected in any forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed in these forward-looking statements. Changes in the circumstances upon which we base our predictions and/or forward-looking statements could materially affect our actual results.

For information, please contact: Oncology Med, Inc. Email Contact